ESTRIAEPHIL AUTOLOGOUS EXOFILL Trademark

Trademark Overview


On Thursday, June 13, 2024, a trademark application was filed for ESTRIAEPHIL AUTOLOGOUS EXOFILL with the United States Patent and Trademark Office. The USPTO has given the ESTRIAEPHIL AUTOLOGOUS EXOFILL trademark a serial number of 79404339. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, December 18, 2024. This trademark is owned by REMEDI S.à. r.l.. The ESTRIAEPHIL AUTOLOGOUS EXOFILL trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments; medical devices for tissue-regeneration.

General Information


Serial Number79404339
Word MarkESTRIAEPHIL AUTOLOGOUS EXOFILL
Filing DateThursday, June 13, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateWednesday, December 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical apparatus and instruments; medical devices for tissue-regeneration.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREMEDI S.à. r.l.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLU

Trademark Events


Event DateEvent Description
Thursday, September 12, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, September 19, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, October 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 7, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, December 18, 2024ASSIGNED TO EXAMINER